24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo Nicolas Gilles, PhDResearch Director, CEA & Co-Founder & CSO at V4CureSpeaker
Profile
Dr. Nicolas Gilles is an expert in the study of animal toxins. He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class. His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations, to in vivo validation. When the pharmacological properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic development initiates through a dedicated start-up. |
Agenda Sessions
From Animal Venom to a Therapeutic Peptide Candidate: Engineering MQ232, an Ultra-Selective V2R Antagonist
, 4:15pmView Session